39267-04-4

Basic information

• Product Name: 2,3-Dichloro-6-methoxyquinoxaline
• Synonyms: Quinoxaline, 2,3-dichloro-6-Methoxy-;2,3-Dichloro-6-methoxy-1,4-benzodiazine;Grazoprevir Intermediate 1;EOS-61016
• CAS NO: 39267-04-4
• Molecular Formula: C₉H₆Cl₂N₂O
• Molecular Weight: 229.06
• Product Categories: intermediates
• Mol File: 39267-04-4.mol
• Article Data: 23

Chemical Properties

• Boiling Point: 312.6 °C at 760 mmHg
• Flash Point: 142.9 °C
• Appearance: /
• Density: 1.450
• Vapor Pressure: 0.00096mmHg at 25°C
• Refractive Index: 1.637
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 2,3-Dichloro-6-methoxyquinoxaline(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-Dichloro-6-methoxyquinoxaline(39267-04-4)
• EPA Substance Registry System: 2,3-Dichloro-6-methoxyquinoxaline(39267-04-4)

Safety Data

• Hazardous Substances Data: 39267-04-4(Hazardous Substances Data)

Usage

Description

2,3-Dichloro-6-methoxyquinoxaline is an organic compound with the molecular formula C8H5Cl2N2O. It is a heterocyclic compound featuring a quinoxaline ring structure with a methoxy group at the 6th position and two chlorine atoms at the 2nd and 3rd positions. 2,3-Dichloro-6-methoxyquinoxaline is known for its potential applications in the synthesis of various pharmaceuticals and chemicals.

Uses

Used in Pharmaceutical Industry:
2,3-Dichloro-6-methoxyquinoxaline is used as a reactant or reagent for the preparation of antibacterial and antifungal agents. Specifically, it is utilized in the synthesis of (tetrazolo[1,5-a]quinoxalinyl)dihydrophthalazine-diones, which possess significant activity against bacterial and fungal infections. 2,3-Dichloro-6-methoxyquinoxaline's structural features make it a valuable building block for the development of new drugs targeting resistant pathogens.

InChI:InChI=1/C9H6Cl2N2O/c1-14-5-2-3-6-7(4-5)13-9(11)8(10)12-6/h2-4H,1H3

Upstream product

• 67-56-1 methanol 
• 31910-18-6 2,3-dioxo-6-methoxy-1,2,3,4-tetrahydroquinoxaline 
• 924-44-7 glyoxylic acid ethyl ester 
• 59548-39-9 4-methoxyphenylene-1,2-diamine dihydrochloride 
• 16133-49-6 5-methoxy-2-nitroaniline 
• 31910-18-6 2,3-dihydroxy-6-methoxyquinoxaline 
• 91192-32-4 6-methoxyquinoxalin-2-ol 
• 55687-30-4 7-methoxyquinoxalin-2-ol 
• 102-51-2 4-methoxy-1,2-phenylenediamine 
• 96-96-8 4-methoxy-2-nitroaniline 
• 119-81-3 4-methoxy-2-nitroacetanilide 
• 51-66-1 4-methoxyacetanilide 
• 104-94-9 4-methoxy-aniline 
• 102-69-2 tri-n-propylamine 

Downstream Products

• 1261078-47-0 (2E,2'E)-diethyl 3,3'-(((6-methoxyquinoxaline-2,3-diyl)bis(azanediyl))bis(4,1-phenylene))diacrylate 
• 1425038-23-8 methyl (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-18,19-didehydro-1,1a,3,4,5,6,9,10,20,21,22,22a-dodecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3, 6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylate 
• 1361028-94-5 methyl (4R)-4-[(3-chloro-7-methoxyquinoxalin-2-yl)oxy]-L-prolinate hydrochloride 
• 1425038-20-5 (2S,4R)-4-[(3-chloro-7-methoxyquinoxalin-2-yl)oxy]-2-(methoxycarbonyl)pyrrolidin-1-ium methanesulfonate 

Relevant articles and documents

Novel molecular targeting anti-tumor aza-steroid derivative based on lipid toxicity and preparation and application thereof

The invention provides a novel molecular targeting anti-tumor aza-steroid derivative based on lipid toxicity and a preparation method and application thereof, and belongs to the field of chemical medicines. The derivative is a compound as shown in a formula I, or a salt thereof, or a stereoisomer thereof. The compound is low in toxicity or basically non-toxic to normal cells, has an obvious inhibition effect to tumor cell lines, particularly has good lipid toxicity selectivity to tumor cells such as liver cancer, lung cancer and the like in vivo, and has an obvious inhibition effect; meanwhile, the compound can effectively activate SREBP1 and PPAR gamma, inhibit lipid transport MTTP, cause lipid aggregation in tumor cells and cause lipid toxicity of the tumor cells. The compound can be used for treating liver cancer, lung cancer and the like in a molecular targeting manner, is low in toxicity or even non-toxic, and has a good application prospect.

NS3/4A protease inhibitor intermediate as well as synthesis method and application thereof

The invention belongs to the technical field of medicine, and particularly relates to an NS3/4A protease inhibitor intermediate as well as a synthesis method and application thereof. The synthesis method comprises the following steps: taking 4-methoxy-o-p

Method for preparing 2,3-dichloro-quinoxaline derivative through one-pot procedure

The invention belongs to the field of drug synthesis, and specifically relates to a new method for preparing 2,3-dichloro-quinoxaline derivative through one-pot procedure. According to the method, cheap o-phenylenediamine and oxalic acid are adopted as raw materials, and the cheap and easily available and environmentally friendly silica gel or methanesulfonic acid is adopted as a catalyst while steps of intermediate separation and purification are omitted; the method has the advantages of easiness in operation, low cost, mild reaction conditions and environmental friendliness and promotes industrial mass production.